Drawing from CAF strategies, inhibiting netrin-1, a CAF-derived factor that promotes cancer cell stemness, could target CAA-derived factors that sustain dedifferentiated, tumor-supportive states, thereby reducing their plasticity-driven effects on tumor progression [120, 121]. The gene discussed is NTN1; the disease is neoplasm.